BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 27884769)

  • 1. Upregulation of CD74 and its potential association with disease severity in subjects with ischemic stroke.
    Yang L; Kong Y; Ren H; Li M; Wei CJ; Shi E; Jin WN; Hao J; Vandenbark AA; Offner H
    Neurochem Int; 2017 Jul; 107():148-155. PubMed ID: 27884769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage migration inhibitory factor receptor CD74 mediates alphavirus-induced arthritis and myositis in murine models of alphavirus infection.
    Herrero LJ; Sheng KC; Jian P; Taylor A; Her Z; Herring BL; Chow A; Leo YS; Hickey MJ; Morand EF; Ng LF; Bucala R; Mahalingam S
    Arthritis Rheum; 2013 Oct; 65(10):2724-36. PubMed ID: 23896945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Near Cure" treatment of severe acute EAE in MIF-1-deficient female and male mice with a bifunctional MHCII-derived molecular construct.
    Vandenbark AA; Meza-Romero R; Wiedrick J; Gerstner G; Seifert H; Kent G; Piechycna M; Benedek G; Bucala R; Offner H
    Cell Immunol; 2022 Aug; 378():104561. PubMed ID: 35738135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory Marker Testing Identifies CD74 Expression in Melanoma Tumor Cells, and Its Expression Associates with Favorable Survival for Stage III Melanoma.
    Ekmekcioglu S; Davies MA; Tanese K; Roszik J; Shin-Sim M; Bassett RL; Milton DR; Woodman SE; Prieto VG; Gershenwald JE; Morton DL; Hoon DS; Grimm EA
    Clin Cancer Res; 2016 Jun; 22(12):3016-24. PubMed ID: 26783288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Transcriptional Factors of T Helper Differentiation (T-bet, GATA-3, RORγt, and FOXP3), MIF Receptors (CD44, CD74, CXCR2, 4, 7), and Th1, Th2, and Th17 Cytokines in PBMC from Control Subjects and Rheumatoid Arthritis Patients.
    Hernández DAZ; Chagollán MG; Zuno GAS; Arellano SG; Bello JH; Palma LAH; Cruz SC; Bonilla GM; Nicoletti F; Valle JFM
    Curr Mol Med; 2023 Oct; ():. PubMed ID: 37807647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-8 secreted in a macrophage migration-inhibitory factor- and CD74-dependent manner regulates B cell chronic lymphocytic leukemia survival.
    Binsky I; Haran M; Starlets D; Gore Y; Lantner F; Harpaz N; Leng L; Goldenberg DM; Shvidel L; Berrebi A; Bucala R; Shachar I
    Proc Natl Acad Sci U S A; 2007 Aug; 104(33):13408-13. PubMed ID: 17686984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage migration inhibitory factor receptor CD74 expression is associated with expansion and differentiation of effector T cells in COVID-19 patients.
    Westmeier J; Brochtrup A; Paniskaki K; Karakoese Z; Werner T; Sutter K; Dolff S; Limmer A; Mittermüller D; Liu J; Zheng X; Koval T; Kaidashev I; Berger MM; Herbstreit F; Brenner T; Witzke O; Trilling M; Lu M; Yang D; Babel N; Westhoff T; Dittmer U; Zelinskyy G
    Front Immunol; 2023; 14():1236374. PubMed ID: 37946732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of the Macrophage Migration Inhibitory Factor (MIF) in Lipedema.
    Vasella M; Wolf S; Francis EC; Grieb G; Pfister P; Reid G; Bernhagen J; Lindenblatt N; Gousopoulos E; Kim BS
    Metabolites; 2023 Oct; 13(10):. PubMed ID: 37887430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MIF and CD74 as Emerging Biomarkers for Immune Checkpoint Blockade Therapy.
    Fey RM; Nichols RA; Tran TT; Vandenbark AA; Kulkarni RP
    Cancers (Basel); 2024 May; 16(9):. PubMed ID: 38730725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of N-benzyl-benzoxazol-2-ones as receptor antagonists of macrophage migration inhibitory factor (MIF).
    Hare AA; Leng L; Gandavadi S; Du X; Cournia Z; Bucala R; Jorgensen WL
    Bioorg Med Chem Lett; 2010 Oct; 20(19):5811-4. PubMed ID: 20728358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Partial MHC Class II Construct, DRmQ, Inhibits Central and Peripheral Inflammatory Responses to Promote Neuroprotection in Experimental Stroke.
    Lee JY; Castelli V; Bonsack B; Coats AB; Navarro-Torres L; Garcia-Sanchez J; Kingsbury C; Nguyen H; Vandenbark AA; Meza-Romero R; Offner H; Borlongan CV
    Transl Stroke Res; 2020 Aug; 11(4):831-836. PubMed ID: 31797249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapeutic treatment of inflammation in mice exposed to methamphetamine.
    Loftis JM; Ramani S; Firsick EJ; Hudson R; Le-Cook A; Murnane KS; Vandenbark A; Shirley RL
    Front Psychiatry; 2023; 14():1259041. PubMed ID: 38025429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissecting the
    Nothnick WB; Graham A
    Biomedicines; 2022 Jul; 10(7):. PubMed ID: 35885004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical study of CD74 biomarker in normal and malignant breast tissues.
    Hassan HN; Al-Hussein RKA; Al-Naqeeb AA
    Pol Merkur Lekarski; 2024; 52(2):233-239. PubMed ID: 38642360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-cell RNA sequencing reveals immune cell dysfunction in the peripheral blood of patients with highly aggressive gastric cancer.
    Ma R; Zhou X; Zhai X; Wang C; Hu R; Chen Y; Shi L; Fang X; Liao Y; Ma L; Jiang M; Wu J; Wang R; Chen J; Cao T; Du G; Zhao Y; Wu W; Chen H; Li S; Lian Q; Guo G; Xiao J; Hutchins AP; Yuan P
    Cell Prolif; 2024 May; 57(5):e13591. PubMed ID: 38319150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the Role of CD74 and D-Dopachrome Tautomerase in COVID-19: Insights from Transcriptomic and Serum Analyses.
    Ralchev Ralchev N; Lyubenova Bradyanova S; Valerieva Doneva Y; Mihaylova N; Vikentieva Elefterova-Florova E; Ivanov Tchorbanov A; Munoz-Valle JF; Petralia MC; Checconi P; Nicoletti F; Fagone P
    J Clin Med; 2023 Jul; 12(15):. PubMed ID: 37568438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD74 is expressed in a subset of pediatric acute myeloid leukemia patients and is a promising target for therapy: a report from the Children's Oncology Group.
    Menssen AJ; Hudson CA; Alonzo T; Gerbing R; Pardo L; Leonti A; Cook JA; Hsu FC; Lott LL; Dai F; Fearing C; Ghirardelli K; Hylkema T; Tarlock K; Loeb KR; Kolb EA; Cooper T; Pollard J; Wells DA; Loken MR; Aplenc R; Meshinchi S; Brodersen LE
    Haematologica; 2024 Feb; ():. PubMed ID: 38299667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major histocompatibility complex Class II-based therapy for stroke.
    Gonzales-Portillo BM; Lee JY; Vandenbark AA; Offner H; Borlongan CV
    Brain Circ; 2021; 7(1):37-40. PubMed ID: 34084976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disrupting T cell memory to promote stress resilience: A role for CD74?
    Vecchiarelli HA; Tremblay MÈ
    Brain Behav Immun; 2023 Nov; 114():240-241. PubMed ID: 37574175
    [No Abstract]   [Full Text] [Related]  

  • 20. Next-generation regenerative therapy for ischemic stroke using peripheral blood mononuclear cells.
    Kanazawa M; Ninomiya I; Otsu Y; Hatakeyama M
    Neural Regen Res; 2024 Nov; 19(11):2341-2342. PubMed ID: 38526265
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.